top of page

[서화목] Shares of pharmaceutical company Moderna rose 3.49%

  • 작성자 사진: 정훈 신
    정훈 신
  • 2021년 10월 15일
  • 1분 분량


ree

Shares of U.S. pharmaceutical company Moderna, which is developing a new coronavirus infection vaccine, rose 3.49% as of 8:28 p.m. on the 29th (local time).


Moderna's rise on this day is due to data showing that mRNA-1273, a candidate for the Covid-19 vaccine, formed the same level of neutralizing antibodies not only in the young but also in the elderly.


The research data was published in the New England Journal of Medicine.


The study, an extension of phase I tests for adults aged 18–55, tested two vaccines (25 micrograms and 100 micrograms) for 40 people in two groups, aged 56–70 and over 71.


Participants who received 100 micrograms of capacity showed the same immune response as young adults.


In terms of safety, no serious side effects were observed.

 
 
 

댓글


Hot Button Issues
스크린샷 2025-08-24 오후 11.55_edited.jpg
Recommanded Reading
Follow "THIS JUST IN"
  • Facebook Basic Black
  • Twitter Basic Black
  • Black Google+ Icon

​청소년 보호 담당자 : 서화목  (01037903011)

등록번호 : 서울, 아5407 

제      호 : 매일경제뉴스

종      별 : 인터넷신문

발 행 소 : 서울특별시 강서구 강서로 54길 27

발행 목적 : 최신뉴스, 정치,경제, iT흐름을 국내외의 범국민들에게 자세히 신속 정확 전달

bottom of page